Anzenbacher P - Search Results

1

Effect of DSS-Induced Ulcerative Colitis and Butyrate on the Cytochrome P450 2A5: Contribution of the Microbiome.

Satka S, Frybortova V, Zapletalova I, Anzenbacher P, Anzenbacherova E, Kozakova H, Srutkova D, Hudcovic T, Jourova L. Satka S, et al. Among authors: anzenbacher p. Int J Mol Sci. 2022 Oct 1;23(19):11627. doi: 10.3390/ijms231911627. Int J Mol Sci. 2022. PMID: 36232929 Free PMC article.

2

Presence and activity of cytochrome P450 isoforms in minipig liver microsomes. Comparison with human liver samples.

Anzenbacher P, Soucek P, Anzenbacherová E, Gut I, Hrubý K, Svoboda Z, Kvĕtina J. Anzenbacher P, et al. Drug Metab Dispos. 1998 Jan;26(1):56-9. Drug Metab Dispos. 1998. PMID: 9443853

3

Potential cancerostatic benfluron is metabolized by peroxidase: in vitro biotransformation of benfluron by horseradish peroxidase.

Hrubý K, Anzenbacherová E, Anzenbacher P, Nobilis M. Hrubý K, et al. Among authors: anzenbacher p. Gen Physiol Biophys. 1997 Dec;16(4):321-7. Gen Physiol Biophys. 1997. PMID: 9595301

4

Flexibility and stability of the structure of cytochromes P450 3A4 and BM-3.

Anzenbacherová E, Bec N, Anzenbacher P, Hudecek J, Soucek P, Jung C, Munro AW, Lange R. Anzenbacherová E, et al. Among authors: anzenbacher p. Eur J Biochem. 2000 May;267(10):2916-20. doi: 10.1046/j.1432-1327.2000.01305.x. Eur J Biochem. 2000. PMID: 10806389 Free article.

5

Use of a propafenone metabolic ratio as a measure of CYP2D6 activity.

Anzenbacherová E, Anzenbacher P, Perlik F, Kvetina J. Anzenbacherová E, et al. Among authors: anzenbacher p. Int J Clin Pharmacol Ther. 2000 Sep;38(9):426-9. doi: 10.5414/cpp38426. Int J Clin Pharmacol Ther. 2000. PMID: 11020029

6

Hudecek J, Anzenbacherová E, Anzenbacher P, Munro AW, Hildebrandt P. Hudecek J, et al. Among authors: anzenbacher p. Arch Biochem Biophys. 2000 Nov 1;383(1):70-8. doi: 10.1006/abbi.2000.2034. Arch Biochem Biophys. 2000. PMID: 11097178

7

Human hepatocyte--a model for toxicological studies. Functional and biochemical characterization.

Modrianský M, Ulrichová J, Bachleda P, Anzenbacher P, Anzenbacherová E, Walterová D, Simánek V. Modrianský M, et al. Among authors: anzenbacher p. Gen Physiol Biophys. 2000 Jun;19(2):223-35. Gen Physiol Biophys. 2000. PMID: 11156444

8

Determination of enzyme (angiotensin convertase) inhibitors based on enzymatic reaction followed by HPLC.

Anzenbacherová E, Anzenbacher P, Macek K, Kvĕtina J. Anzenbacherová E, et al. Among authors: anzenbacher p. J Pharm Biomed Anal. 2001 Mar;24(5-6):1151-6. doi: 10.1016/s0731-7085(00)00576-8. J Pharm Biomed Anal. 2001. PMID: 11248513

9

Cytochromes P450 and metabolism of xenobiotics.

Anzenbacher P, Anzenbacherová E. Anzenbacher P, et al. Cell Mol Life Sci. 2001 May;58(5-6):737-47. doi: 10.1007/pl00000897. Cell Mol Life Sci. 2001. PMID: 11437235 Review.

10

Minipig cytochrome P450 3A, 2A and 2C enzymes have similar properties to human analogs.

Soucek P, Zuber R, Anzenbacherová E, Anzenbacher P, Guengerich FP. Soucek P, et al. Among authors: anzenbacher p. BMC Pharmacol. 2001;1:11. doi: 10.1186/1471-2210-1-11. Epub 2001 Dec 5. BMC Pharmacol. 2001. PMID: 11737866 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

236 results

Search Page